analytica InnovationArea: Start-ups in the Spotlight

23-26 March 2010, Munich, Germany.
Following its successful premiere in 2008, analytica, the leading trade fair for industrial analysis, laboratory technology and biotechnology, will continue its initiative for new companies again in 2010. International start-ups and research organizations in the biotechnology sector will present their business ideas and document the importance of the life sciences in a special area known as the InnovationArea. Lectures and panel discussions at the Biotech Forum, which is located in the immediate vicinity of the InnovationArea, will give visitors additional insights into the trends and innovative strength of this industry.

The fact that research and development are heavily influenced by the innovative strength of new, smaller companies is well-known in the life-sciences sector. Each year the biotech industry grows by several dozen new companies. The research results of these start-ups and research institutes give the industry direction and important impetus. "The InnovationArea expands the scope of the traditional exhibition sectors at analytica to include an important, fundamental branch of industry, i.e. research and development. It gives new companies and research institutes in this sector a perfect platform for presenting their innovations, products, services, research results and business ideas to a broad-based domestic and international audience. It also gives them an opportunity to make new contacts and cultivate existing ones - and at attractive rates," says Thomas Rehbein, Exhibition Director of analytica, explaining the concept of the special exhibition sector.

However, the InnovationArea is more than just a cluster of exhibits. Its close physical proximity to the Biotech Forum and the fact that the themes of both platforms are closely related is intended to promote dialog. On all four days of the fair, the presentation stage will feature discussions and presentations about future technologies and research trends in the life sciences. The most important topics include industrial biotechnology and personalized healthcare, and Finance Day on Friday will examine ways to financially support new research organizations and start-ups.

The InnovationArea was an immediate success when it celebrated its premiere in 2008. The compact platform featured new biotech and life-science companies as well as start-ups in the nano-chemistry, micro-reaction technology and bioinformatics sectors. The fact that it got off to such as successful start is also reflected by the ratings that the InnovationArea received. Eighty percent of all exhibitors gave the new attraction a rating of good to excellent - ratings that it received by an impressive 85 percent of all visitors.

The basic perquisites for participating in the InnovationArea as well as all relevant facts and figures and an application form are available online at www.analytica.de/link/en/innovationarea.

About analytica
analytica, which includes the Analytica Conference, is the leading European trade fair for analysis, laboratory technology, biotechnology/life sciences, diagnostics and data and process management. It is held in Munich, the leading trade-fair venue and business location in the world. Visitors include decision-makers and users from the chemical, medical and pharmaceutical sectors as well as industrial and government research organizations. Analytica is held every two years and has established itself as a central marketplace for marketable products and solutions as well as innovations. The 22nd analytica is being held at the New Munich Trade Fair Centre from March 23-26, 2010.

analytica is part of an international network of trade fairs: It includes the trade fairs analytica, analytica China (Shanghai, Sept. 15-17, 2010), analytica Anacon India (Fall 2011) and analytica Vietnam (April 7-9, 2011). Additional information about the fair(s) and the program of events is available on the Internet at www.analytica.de.

Messe München International (MMI)
Messe München International (MMI) is one of the world's leading trade-fair companies. It organises around 40 trade fairs for capital and consumer goods, and key high-tech industries. Each year over 30,000 exhibitors from more than 100 countries, and over two million visitors from more than 200 countries take part in the events in Munich. In addition, MMI organises trade fairs in Asia, Russia, the Middle East and South America. With six subsidiaries abroad - in Europe and in Asia - and with 64 foreign representatives serving 89 countries, MMI has a truly global network. Via its six subsidiaries - in Europe and in Asia - and 64 foreign representatives actively serving over 90 countries, MMI has a worldwide business network. Environmental protection and sustainability are key priorities in all MMI's operations, at home and abroad.

Further information: www.messe-muenchen.de.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...